about
Glutamate and its receptors in cancerPreliminary results of prognostic significance of proliferating cell nuclear antigen expression in advanced primary larynx carcinomas and lymph node metastasesAssessment of Interactions between Cisplatin and Two Histone Deacetylase Inhibitors in MCF7, T47D and MDA-MB-231 Human Breast Cancer Cell Lines - An Isobolographic Analysis.Inhibition of mitochondrial 2-oxoglutarate dehydrogenase impairs viability of cancer cells in a cell-specific metabolism-dependent manner.MicroRNAs-role in lung cancer.Xanthohumol inhibits the extracellular signal regulated kinase (ERK) signalling pathway and suppresses cell growth of lung adenocarcinoma cells.Discovery of nitroaryl urea derivatives with antiproliferative properties.Betulin elicits anti-cancer effects in tumour primary cultures and cell lines in vitro.Effect of carotid endarterectomy on brain damage markers.The intermediate filament protein keratin 8 is a novel cytoplasmic substrate for c-Jun N-terminal kinase.REPLACR-mutagenesis, a one-step method for site-directed mutagenesis by recombineering.Xanthohumol inhibits cell cycle progression and proliferation of larynx cancer cells in vitro.Comprehensive review on betulin as a potent anticancer agent.Histone Deacetylase Inhibitor SAHA as Potential Targeted Therapy Agent for Larynx Cancer CellsThe role of matrix metalloproteinases in infant traumatic brain injury.Mechanisms leading to disseminated apoptosis following NMDA receptor blockade in the developing rat brain.Reactive oxygen species production by blood neutrophils of patients with laryngeal carcinoma and antioxidative enzyme activity in their blood.Optogenetics in cancer drug discovery.Tumor angiogenesis in patients with laryngeal cancerMMP-9 and MMP-2 regulation in patients undergoing non-oncological and non-vascular elective surgery independent of the use of propofol or sevofluraneHistone deacetylase inhibitors reinforce the phenotypical markers of breast epithelial or mesenchymal cancer cells but inhibit their migratory propertiesSynergistic or Additive Pharmacological Interactions between Magnoflorine and Cisplatin in Human Cancer Cells of Different Histological OriginImperatorin as a Promising Chemotherapeutic Agent Against Human Larynx Cancer and Rhabdomyosarcoma Cells
P50
Q34048497-1F673404-B45D-4857-B02B-F422BAC28C7AQ35755351-81761847-FB49-4FEF-B11B-FA9CA9AAAEEBQ35845089-A4DA68E8-068A-40F0-90D4-8F22DB98DA70Q37295678-7CC6E933-7091-4B65-952F-90FBB69978E5Q37679619-53F5AA9E-4A0B-4BCB-B060-87EFB2E73690Q38763708-8BDE770C-19B0-4A22-A458-06ACBF56313CQ38859827-0FB95B04-DDDC-4328-8956-A7A9150B2818Q39788560-42C8A8D6-81D6-4ABB-A167-8E3ED9ACFB1FQ39811657-117265C7-CD2B-4B72-9459-197559E2E713Q40758343-EC71EDFA-2A72-45A7-90A3-D897741F195FQ40988187-D492A2BB-5CFA-4856-BFFD-BEB88050775DQ41461063-AFEE948D-9DA7-4790-A4EB-8C12CFA3CBC4Q41839933-3B57FFD3-E9D4-49F0-B6DB-21848B62BB21Q42328146-5663A4AE-A71E-4580-B650-251414808D72Q42506049-6EFF7EC8-6CE1-40C1-AC77-ABEB37C8D9A0Q44933234-19EBA79A-C7DB-4046-B5AB-E7A032FF1CB5Q44971114-C9299CF1-219B-4429-B928-0C3DC26FC240Q49982038-A4387D04-6F9F-47DC-87A2-4CA85751ECB9Q78154913-43CBBCD9-AB67-4616-A455-4ABBC1DB7A24Q90249295-2E4F9F46-8DBC-41B7-AA49-E5697AA52BEDQ90398667-6F6B42D3-8310-49F3-B8BC-DCC4C4BDF140Q93185322-B8241A7D-626D-46FC-BED5-A31BBB450D56Q94470930-946DC7FE-B5CD-4725-B961-D7D2848528A9
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Andrzej Stepulak
@ast
Andrzej Stepulak
@en
Andrzej Stepulak
@es
type
label
Andrzej Stepulak
@ast
Andrzej Stepulak
@en
Andrzej Stepulak
@es
prefLabel
Andrzej Stepulak
@ast
Andrzej Stepulak
@en
Andrzej Stepulak
@es
P106
P1153
6602946595
P21
P31
P496
0000-0002-1872-394X